X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Natco Pharma Ltd.
BSE CODE: 524816   |   NSE CODE: NATCOPHARM   |   ISIN CODE : INE987B01026   |   22-Jan-2025 Hrs IST
BSE NSE
Rs. 1262.45
19.1 ( 1.54% )
 
Prev Close ( Rs.)
1243.35
Open ( Rs.)
1259.60
 
High ( Rs.)
1269.95
Low ( Rs.)
1234.45
 
Volume
48575
Week Avg.Volume
20474
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1262.85
19.85 ( 1.6% )
 
Prev Close ( Rs.)
1243.00
Open ( Rs.)
1253.45
 
High ( Rs.)
1269.95
Low ( Rs.)
1233.30
 
Volume
435619
Week Avg.Volume
318280
 
52 WK High-Low Range(Rs.)
828
1639
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)72.99  34.91  7.62  16.96  26.07  
   CEPS(Rs)82.60  43.18  15.21  23.27  31.46  
   DPS(Rs)9.50  5.50  4.50  5.25  6.75  
   Book NAV/Share(Rs)312.42  257.64  229.51  223.21  211.31  
   Tax Rate(%)15.99  17.33  10.78  21.09  18.62  
Margin Ratios          
   Core EBITDA Margin(%)43.56  34.23  11.56  24.64  30.61  
   EBIT Margin(%)41.77  32.50  9.18  23.94  31.97  
   Pre Tax Margin(%)41.39  32.14  8.46  23.27  30.88  
   PAT Margin (%)34.77  26.57  7.55  18.36  25.13  
   Cash Profit Margin (%)39.34  32.87  15.06  25.20  30.32  
Performance Ratios          
   ROA(%)21.90  12.29  2.86  6.59  10.54  
   ROE(%)25.38  14.33  3.37  7.82  12.86  
   ROCE(%)29.02  16.51  3.79  9.46  14.85  
   Asset Turnover(x)0.63  0.46  0.38  0.36  0.42  
   Sales/Fixed Asset(x)1.15  0.78  0.65  0.70  0.99  
   Working Capital/Sales(x)1.49  1.25  1.22  1.02  1.20  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.87  1.28  1.53  1.43  1.01  
   Receivable days90.80  104.18  96.61  101.41  99.38  
   Inventory Days58.90  100.00  145.29  140.07  99.81  
   Payable days126.93  121.62  102.03  144.40  215.17  
Valuation Parameters          
   PER(x)13.04  16.15  99.36  48.66  19.41  
   PCE(x)11.52  13.05  49.80  35.46  16.09  
   Price/Book(x)3.05  2.19  3.30  3.70  2.40  
   Yield(%)1.00  0.98  0.59  0.64  1.33  
   EV/Net Sales(x)4.63  4.27  7.98  9.10  5.29  
   EV/Core EBITDA(x)9.49  10.79  45.87  29.02  13.49  
   EV/EBIT(x)10.53  12.88  83.39  37.30  15.69  
   EV/CE(x)2.78  2.06  3.08  3.46  2.26  
   M Cap / Sales4.77  4.38  7.82  9.11  5.15  
Growth Ratio          
   Net Sales Growth(%)51.80  32.99  6.91  -7.64  -9.87  
   Core EBITDA Growth(%)87.24  202.41  -40.70  -26.09  -25.84  
   EBIT Growth(%)101.44  360.58  -58.07  -33.16  -30.30  
   PAT Growth(%)105.09  358.02  -55.06  -34.77  -28.87  
   EPS Growth(%)109.10  358.02  -55.06  -34.95  -28.68  
Financial Stability Ratios          
   Total Debt/Equity(x)0.06  0.03  0.09  0.06  0.08  
   Current Ratio(x)3.85  4.38  3.33  4.18  3.40  
   Quick Ratio(x)3.23  3.36  2.32  2.79  2.65  
   Interest Cover(x)108.26  90.62  12.72  35.71  29.31  
   Total Debt/Mcap(x)0.02  0.02  0.03  0.02  0.03